Ewa Surmiak

Terphenyl-Based Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein–Protein Interaction

Damian Muszak, Ewa Surmiak, Jacek Plewka et al. · Journal of Medicinal Chemistry · 2021 · 91 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 Antagonists

Roberto Butera, Marta A. Ważyńska, Katarzyna Magiera‐Mularz et al. · ACS Medicinal Chemistry Letters · 2021 · 57 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Multicomponent Peptide Stapling as a Diversity‐Driven Tool for the Development of Inhibitors of Protein–Protein Interactions

Manuel G. Ricardo, Ameena M. Ali, Jacek Plewka et al. · Angewandte Chemie International Edition · 2020 · 52 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action

Ewa Surmiak, Katarzyna Magiera‐Mularz, Bogdan Musielak et al. · International Journal of Molecular Sciences · 2021 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

A Unique Mdm2-Binding Mode of the 3-Pyrrolin-2-one- and 2-Furanone-Based Antagonists of the p53-Mdm2 Interaction

Ewa Surmiak, Aleksandra Twarda‐Clapa, Krzysztof M. Żak et al. · ACS Chemical Biology · 2016 · 34 citations · Full text

Medicine, Medicinal Chemistry, Oncology +13